FDA sends user-fee recommendations to Congress

Category: Health

Publish Date: 01-13-2012 02:45 PM -0800

WASHINGTON (Reuters) - U.S. health regulators said on Friday they have submitted to Congress new recommendations for how manufacturers will help fund their review of new branded drugs, conventional generic medicines and a new generation of generic biotech treatments.

Continue to Original Story >